BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP

10% owner at PONIARD PHARMACEUTICALS, INC. · on record since May 4, 2006
10% owner at VIA Pharmaceuticals, Inc. · on record since Jun 7, 2007
10% owner at ReShape Weightloss Inc. · on record since Nov 20, 2007
Former 10% Beneficial Owner at NEVRO CORP · on record since Nov 12, 2014
10% owner at NEVRO CORP · on record since Nov 5, 2014
Director at MADRIGAL PHARMACEUTICALS, INC. · on record since Jul 26, 2016
10% owner at MADRIGAL PHARMACEUTICALS, INC. · on record since Jul 26, 2016

Insider trading activity of BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP

Transactions on record: 69; since Apr 30, 2007

Open-market buys: 36; $10.9M

Open-market sells: 2; $126.6M

Companies traded: 5; last filing Sep 4, 2020

Figures computed from official regulatory filings — .

Companies where BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP has traded

MADRIGAL PHARMACEUTICALS, INC.5 tx · $126.6M · Sep 4, 2020
NEVRO CORP12 tx · Nov 12, 2014
ReShape Weightloss Inc.16 tx · $3.4M · Sep 26, 2011
VIA Pharmaceuticals, Inc.6 tx · $3.7M · Nov 16, 2010
PONIARD PHARMACEUTICALS, INC.30 tx · $7.6M · Aug 31, 2007

Track record of BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP

Statistical track record

Free account

Open-market buys: 46

Last buy: Sep 23, 2011

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP

Co-insiders of BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Sep 4, 2020	Other	-31,650	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Sep 4, 2020	Other	-1,468,350	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Sep 4, 2020	Other	-45,460	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Dec 13, 2019	Sell	-1,174,680	105.47 USD	$123.9M		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Dec 13, 2019	Sell	-25,320	105.47 USD	$2.7M		SEC
NEVRO CORPListing unverified	Nov 12, 2014	Other	1,272,841	—	n/a (No price was disclosed in the filing)		SEC
NEVRO CORPListing unverified	Nov 12, 2014	OtherD (derivative)	-14,718	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEVRO CORPListing unverified	Nov 12, 2014	Other	27,435	—	n/a (No price was disclosed in the filing)		SEC
NEVRO CORPListing unverified	Nov 12, 2014	Other	4,123	—	n/a (No price was disclosed in the filing)		SEC
NEVRO CORPListing unverified	Nov 12, 2014	Other	191,314	—	n/a (No price was disclosed in the filing)		SEC
NEVRO CORPListing unverified	Nov 12, 2014	OtherD (derivative)	-1,272,841	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEVRO CORPListing unverified	Nov 12, 2014	OtherD (derivative)	-27,435	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEVRO CORPListing unverified	Nov 12, 2014	OtherD (derivative)	-4,123	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEVRO CORPListing unverified	Nov 12, 2014	OtherD (derivative)	-191,314	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEVRO CORPListing unverified	Nov 12, 2014	OtherD (derivative)	-682,826	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEVRO CORPListing unverified	Nov 12, 2014	Other	682,826	—	n/a (No price was disclosed in the filing)		SEC
NEVRO CORPListing unverified	Nov 12, 2014	Other	14,718	—	n/a (No price was disclosed in the filing)		SEC
ReShape Weightloss Inc.Listing unverified	Sep 26, 2011	BuyD (derivative)	164,455	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	Cluster	SEC
ReShape Weightloss Inc.Listing unverified	Sep 26, 2011	Buy	17,724	1.65 USD	$29.2K	conv 37Cluster	SEC
ReShape Weightloss Inc.Listing unverified	Sep 26, 2011	BuyD (derivative)	3,545	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	Cluster	SEC
ReShape Weightloss Inc.Listing unverified	Sep 26, 2011	Buy	822,276	1.65 USD	$1.4M	conv 49Cluster	SEC
VIA Pharmaceuticals, Inc.Listing unverified	Nov 16, 2010	BuyD (derivative)	29,985	0.07 USD	$2.1K	ClusterFirst in 12mo	SEC
VIA Pharmaceuticals, Inc.Listing unverified	Nov 16, 2010	BuyD (derivative)	891,549	0.07 USD	$62.4K	ClusterFirst in 12mo	SEC
VIA Pharmaceuticals, Inc.Listing unverified	Nov 16, 2010	BuyD (derivative)	149,927	0.07 USD	$10.5K	ClusterFirst in 12mo	SEC
VIA Pharmaceuticals, Inc.Listing unverified	Nov 16, 2010	BuyD (derivative)	41,361,972	0.07 USD	$2.9M	ClusterUnusual size+1	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Sep 4, 2020	Other	-31,650	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Sep 4, 2020	Other	-1,468,350	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Sep 4, 2020	Other	-45,460	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Dec 13, 2019	Sell	-1,174,680	105.47 USD	$123.9M		SEC
MADRIGAL PHARMACEUTICALS, INC.Listing on record	Dec 13, 2019	Sell	-25,320	105.47 USD	$2.7M		SEC
NEVRO CORPListing unverified	Nov 12, 2014	Other	1,272,841	—	n/a (No price was disclosed in the filing)		SEC
NEVRO CORPListing unverified	Nov 12, 2014	OtherD (derivative)	-14,718	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEVRO CORPListing unverified	Nov 12, 2014	Other	27,435	—	n/a (No price was disclosed in the filing)		SEC
NEVRO CORPListing unverified	Nov 12, 2014	Other	4,123	—	n/a (No price was disclosed in the filing)		SEC
NEVRO CORPListing unverified	Nov 12, 2014	Other	191,314	—	n/a (No price was disclosed in the filing)		SEC
NEVRO CORPListing unverified	Nov 12, 2014	OtherD (derivative)	-1,272,841	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEVRO CORPListing unverified	Nov 12, 2014	OtherD (derivative)	-27,435	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEVRO CORPListing unverified	Nov 12, 2014	OtherD (derivative)	-4,123	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEVRO CORPListing unverified	Nov 12, 2014	OtherD (derivative)	-191,314	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEVRO CORPListing unverified	Nov 12, 2014	OtherD (derivative)	-682,826	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEVRO CORPListing unverified	Nov 12, 2014	Other	682,826	—	n/a (No price was disclosed in the filing)		SEC
NEVRO CORPListing unverified	Nov 12, 2014	Other	14,718	—	n/a (No price was disclosed in the filing)		SEC
ReShape Weightloss Inc.Listing unverified	Sep 26, 2011	BuyD (derivative)	164,455	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	Cluster	SEC
ReShape Weightloss Inc.Listing unverified	Sep 26, 2011	Buy	17,724	1.65 USD	$29.2K	conv 37Cluster	SEC
ReShape Weightloss Inc.Listing unverified	Sep 26, 2011	BuyD (derivative)	3,545	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	Cluster	SEC
ReShape Weightloss Inc.Listing unverified	Sep 26, 2011	Buy	822,276	1.65 USD	$1.4M	conv 49Cluster	SEC
VIA Pharmaceuticals, Inc.Listing unverified	Nov 16, 2010	BuyD (derivative)	29,985	0.07 USD	$2.1K	ClusterFirst in 12mo	SEC
VIA Pharmaceuticals, Inc.Listing unverified	Nov 16, 2010	BuyD (derivative)	891,549	0.07 USD	$62.4K	ClusterFirst in 12mo	SEC
VIA Pharmaceuticals, Inc.Listing unverified	Nov 16, 2010	BuyD (derivative)	149,927	0.07 USD	$10.5K	ClusterFirst in 12mo	SEC
VIA Pharmaceuticals, Inc.Listing unverified	Nov 16, 2010	BuyD (derivative)	41,361,972	0.07 USD	$2.9M	ClusterUnusual size+1	SEC